Urinary Bladder, Overactive: Clinical Trials

5 trials for Urinary Bladder, Overactive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 15Completed 5

Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
Pelvic Floor Muscle Training, Mirabegron, Trospium Chloride - Urinary Bladder, Overactive, Urinary Incontinence
Early Phase 1CompletedThe University of Texas Medical Branch, Galveston482023-09-282026-06-22
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
Transvaginal botulinum toxin A (BTA) injection - Overactive Bladder, Bladder, Overactive
Early Phase 1CompletedStanford University152019-06-202022-07-19
Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron
Mirabegron - Spinal Cord Injuries, Neurogenic Bladder
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio202018-12-052021-06-22
IVES for Treatment of UUI and OAB
EMED detruset(TM) intravesical electrical stimulation - Urinary Bladder, Overactive, Urinary Incontinence, Urge
Early Phase 1CompletedLoma Linda University172014-12-012017-01-04
Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome
MiraLAX, Placebos - Constipation
Early Phase 1CompletedUniversity of Texas Southwestern Medical Center1382007-12-102021-01-15

Narrower conditions

Urinary Incontinence, Urge (2)  ·  Constipation (1)  ·  Spinal Cord Injuries (1)  ·  Urinary Bladder, Neurogenic (1)  ·  Urinary Incontinence (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Lower Urinary Tract Symptoms (5)  ·  Male Urogenital Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Urinary Bladder Diseases (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)  ·  Urological Manifestations (5)  ·  Urination Disorders (3)  ·  Urinary Incontinence (2)  ·  Central Nervous System Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)

Interventions

mirabegron (2)  ·  Glucose (1)  ·  Injections (1)  ·  Polyethylene Glycols (1)  ·  polyethylene glycol 3350 (1)  ·  trospium chloride (1)

Sponsors

Loma Linda University (1)  ·  Stanford University (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (4)

Top investigators

Amy D. Dobberfuhl, M.D. (1)  ·  Michelle Trbovich, MD (1)  ·  Sam Siddighi, MD (1)  ·  Steve Fisher (1)  ·  Warren T Snodgrass, MD (1)

Results publications

PMID 34156506, PMID 35607890, PMID 38178267

NIH funding

R21AG081900 (1)